2025年第10届亚太肝胆胰学会大会(A-PHPBA)

◆ 会议时间：2025年10月28日至31日
◆ 会议地点：泰国 曼谷

◆ 会议简介：

2025年第10届亚太肝胆胰学会(A-PHPBA)大会将于2025年10月28日至31日在泰国曼谷举行，本次会议由亚太肝胆胰学会(A-PHPBA)和泰国肝胆胰外科学会联合举办。

亚太肝胆胰协会学术大会(A-PHPBA大会)是亚太地区肝胆胰外科领域最大、最具影响力的学术会议，每两年召开一次，A-PHPBA大会将成为展示HPB相关疾病的诊断、治疗和外科的先进技术，交流信息和分享有价值的学术研究和案例的最佳机会与平台。众多世界知名的演讲者和代表宣将分享他们在该领域的专业知识、卓越的成就和最新的研究成果，大会将涵盖范围广泛的科学议程，包括讲座、专题讨论会和关于本领域最具挑战性的关键问题的演讲等等；本次A-PHPBA大会预计将吸引来自30多个国家和地区的1500余名代表出席会议。未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网。

亚太肝胆胰协会(A-PHPBA)成立于2006年11月，其宗旨是汇聚亚太地区的HPB专家以分享他们的经验和想法并促进相互理解。A-PHPBA的使命是促进与提高肝胆胰外科和患者护理质量的最高标准。 其目标是：加强对HPB领域的教育、培训、创新和患者护理；传播研究成果和最佳治疗实践，推进HPB专项培训，促进研究和创新，鼓励多学科合作；减轻HPB疾病带给人们的痛苦；改善整个亚太地区以证据为基础的护理，优化HPB疾病患者的预后。

The 10th Biennial Congress of The Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA) 2025 

Date: October 28-31, 2025
Location: Bangkok, Thailand

摘要征文投稿：

Important dates for Abstract submission (Bangkok Time GMT+7)

点此提交摘要>>>Submit Abstract>>>

Click to Dowload Abstract Submission Guideline

General Conditions and Information

Abstract submission is free of charge and must be completed online via the A-PHPBA 2025 Abstract Submission platform. Abstracts sent by email will not be accepted.

Submission of an abstract constitutes a formal commitment by the author(s) to present the work in person in Bangkok at A-PHPBA 2025 Congress, if accepted. Failure to upload and register for the Congress by the set deadline (July 30th, 2025) will lead to the withdrawal of the abstract from the scientific program and all Congress publications (including the online congress platform, the abstract supplement).

A-PHPBA Members and Non-Members are invited to submit abstracts. There are no fees to submit an abstract.

Draft status

Your abstract will be saved in Draft Status by click on the Save Draft button. You will then be able to review it and submit it later before the deadline. Abstracts that are in draft status after the deadline cannot be processed and therefore will not be considered for selection.

Changes and corrections

Once submitted, it is not possible to make any corrections to the abstract content or information (such as authors list and details, topic, conclusion(s) etc…). The A-PHPBA 2025 is not authorized to make changes to a submission. In order to correct your abstract, you must withdraw it and submit a new version prior to the deadline. Note that, such replacement of your abstract is not possible after the deadline. In the case of errors in your abstract discovered after the deadline, you may indicate the correction on your presentation. However, changes will not be included in the publications. If accepted, your abstract will be published as submitted.

Withdrawal

If the presenting author of an accepted abstract does not register by July 30th ,2025, the abstract will be automatically withdrawn from the final program. If you decide to withdrawn an abstract, please notify the A-PHPBA2025 secretariat (abstracts@aphpba2025.com) by July 15th ,2025.

How to Submit an Abstract

1. Create Account: Create a new user account in order to submit an abstract. Once logged in, you will be able to submit your abstract.
2. Contact Information: Complete the information required on the Contact Information tab.

Instructions to Author

1. Presentation Type:
Choose category you wish to submit under from the drop-down menu.
1. Oral Presentation
2. ePoster Presentation
3. Video Presentation (The submitters are required to upload a URL Web link) 2. Abstract Category:
You must select one of the following categories under which your abstract can be best classified.

3. Title:

• Insert the full title of the proposed presentation.
• Do not include authors, institutions, city names, trademarks and abbreviations in the title.

4. Authors & Affiliations:

• Author(s) Affiliation
• Abstract Authors(s)
• The name of the presenting author must appear first in the list of authors

5. Abstract Content

The body of the text must not exceed 300 words, please make the abstract as an informative as possible, and support your conclusion with data, abstracts texts should be structured to conclude the following sections;

1. Background: Indicate the propose of the study.
2. Method: Describe pertinent experimental procedures.
3. Results: Summarize the result of the research.
4. Conclusions: State the main conclusion, please use standard abbreviations, generic drug names, and place unusual abbreviations or acronyms in parenthesis after first use. DO NOT identify author(s) or institution(s) in the text.

6. Options

You may choose to submit your abstract under one of the following options to get a chance to compete for the A-PHPBA 2025 awards.

1. Young Investigator Award (for young investigators (up to 35-year-old) to submit abstracts)
   
   • Cash back travel grant: 100 USD/person
     If accepted for mini-oral or short VDO presentation
   • Cash back travel grant: 200 USD/person
     If accepted for Best oral / VDO presentation
2. APHPBA 2025 Presentation Award
   
   • 4 Best ePoster Presentation in 4 categories: Liver, Biliary, Pancreas, Miscellaneous: 300 USD
   • Plenary Oral Presentation and Plenary Video Presentation
     • 1st Prize: 1,000 USD
     • 2nd Prize: 700 USD
     • 3rd Prize: 500 USD
     • 4th – 7th Prize: 300 USD

7. Publication of abstracts
All accepted abstracts will be published in a supplemental issue of Journal of Hepato-Biliary-Pancreatic Sciences (JHBPS) 8. Scoring:
Selection of the Abstracts for the congress will be scored by A-PHPBA2025 scientific committee. 9. Disclosure Policy/Conflict(s) of interest

The A-PHPBA2025 Scientific Committee requests all presenters to disclose their potential conflict(s) of interest at the time of acceptance of presentation (agreement form submission).It is also the responsibility of the presenter to disclose any potential conflict(s) of interest from co-authors pertaining to the presentation on the presentation itself (as may be required).

This will allow the audience to take potential conflicts of interest into account when assessing the objectivity of the presentation.

A potential conflict of interest may arise from various relationships, past or present, such as employment, consultancy, investments and stock ownership, funding for research, family relationship, etc.

All related potential conflicts of interest must be stated.

This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the article. Such relationships include, but are not limited to, employment by an industrial concern, ownership of stock, membership on a standing advisory council or committee, being on the board of directors, or being publicly associated with the company or its products. Other areas of real or perceived conflict of interest could include receiving honoraria or consulting fees or receiving grants or funds from such corporations or individuals representing such corporations.

注册费：

,

相关文章

2025年艺术设计、音乐与戏剧国际学术会议（ICADMD 2025）

学术会议

3周前

090

新2025智慧能源、智能电网与电气电力国际会议（SESEP 2025）

学术会议

4天前

050

中国生理学会干细胞生理专业委员会2025年年会

学术会议# 学术会议

2个月前

0200

2025年第13届亚太乳腺癌峰会

学术会议# 学术会议

3个月前

0300

暂无评论

再想想 发表评论

暂无评论...